[1] H.Y. Lu, Q. Zhang, Q.X. Wang, J.Y. Lu, Contribution of histologic chorioamnionitis and fetal inflammatory response syndrome to increased risk of brain injury in in- fants with preterm premature rupture of membranes, Pediatr. Neurol. 61 (2016) 94–98.
[2] H. Hagberg, P. Gressens, C. Mallard, Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults, Ann. Neurol. 71 (4) (2012) 444–457.
[3] R. Romero, F. Gotsch, B. Pineles, J.P. Kusanovic, Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury, Nutr. Rev. 65 (12) (2007) S194–S202.
[4] N. Takahashi, R. Uehara, M. Kobayashi, Y. Yada, Y. Koike, R. Kawamata, et al., Cytokine profiles of seventeen cytokines, growth factors and chemokines in cord blood and its relation to perinatal clinical findings, Cytokine 49 (3) (2010) 331–337.
[5] C.W. Heizmann, Ca2+−binding S100 proteins in the central nervous system, Neurochem. Res. 24 (9) (1999) 1097–1100.
[6] I. Bersani, C. Auriti, M.P. Ronchetti, G. Prencipe, D. Gazzolo, A. Dotta, Use of early biomarkers in neonatal brain damage and sepsis: state of the art and future per- spectives, Biomed. Res. Int. 2015 (2015) 1–9.
[7] M. Zaigham, F. Lundberg, P. Olofsson, Protein S100B in umbilical cord blood as a potential biomarker of hypoxic-ischemic encephalopathy in asphyxiated newborns, Early Hum. Dev. 112 (2017) 48–53.
[8] N. Masaoka, Y. Nakajima, M. Morooka, H. Tashiro, M. Wada, K. Maruta, et al., The impact of intrauterine infection on fetal brain damage assessed by S100B protein concentrations in umbilical cord arteries, J. Matern. Fetal Neonatal Med. 29 (15) (2016) 2463–2468.
[9] T. Okai, T. Ikeda, T. Kawarabayashi, S. Kozuma, J. Sugawara, H. Chisaka, et al., Intrapartum management guidelines based on fetal heart rate pattern classification, J. Obstet. Gynaecol. Res. 36 (5) (2010) 925–928.
[10] T.J. Cole, The LMS method for constructing normalized growth standards, Eur. J. Clin. Nutr. 44 (1) (1990) 45–60.
[11] K. Sekii, T. Ishikawa, T. Ogata, H. Itoh, S. Iwashima, Fetal myocardial tissue Doppler indices before birth physiologically change in proportion to body size adjusted for gestational age in low-risk term pregnancies, Early Hum. Dev. 88 (7) (2012) 517–523.
[12] N. Matoba, Y.X. Yu, K. Mestan, C. Pearson, K. Ortiz, N. Porta, et al., Differential patterns of 27 cord blood immune biomarkers across gestational age, Pediatrics 123 (5) (2009) 1320–1328.
[13] K. Imai, T. Kotani, H. Tsuda, T. Nakano, T. Ushida, A. Iwase, et al., Administration of molecular hydrogen during pregnancy improves behavioral abnormalities of offspring in a maternal immune activation model, Sci. Rep. 8 (2018).
[14] J.K. Aronson, Biomarkers and surrogate endpoints, Br. J. Clin. Pharmacol. 59 (5) (2005) 491–494.
[15] D. Gazzolo, R. Abella, E. Marinoni, R. Di Iorio, G.L. Volti, F. Galvano, et al., New markers of neonatal neurology, J. Matern. Fetal Neonatal Med. 22 (2009) 57–61.
[16] F. Michetti, V. Corvino, M.C. Geloso, W. Lattanzi, C. Bernardini, L. Serpero, et al., The S100B protein in biological fluids: more than a lifelong biomarker of brain distress, J. Neurochem. 120 (5) (2012) 644–659.
[17] H.Y. Lu, W.L. Huang, X.Q. Chen, Q.X. Wang, Q. Zhang, M. Chang, Relationship between premature brain injury and multiple biomarkers in cord blood and am- niotic fluid, J. Matern. Fetal Neonatal Med. 31 (21) (2018) 2898–2904.
[18] D. Gazzolo, P. Vinesi, E. Marinoni, R. Di Iorio, M. Marras, M. Lituania, et al., S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries, Clin. Chem. 46 (7) (2000) 998–1000.
[19] R.C. Silveira, R.S. Procianoy, Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy, J. Pediatr. 143 (5) (2003) 625–629.
[20] H. Aly, M.T. Khashaba, M. El-Ayouty, O. El-Sayed, B.M. Hasanein, IL-1 beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy, Brain Dev. 28 (3) (2006) 178–182.
[21] R.M. Viscardi, C.K. Muhumuza, A. Rodriguez, K.D. Fairchild, C.C.J. Sun, G.W. Gross, et al., Inflammatory markers in intrauterine and fetal blood and cere- brospinal fluid compartments are associated with adverse pulmonary and neuro- logic outcomes in preterm infants, Pediatr. Res. 55 (6) (2004) 1009–1017.
[22] I. Hansen-Pupp, S. Harling, A.C. Berg, C. Cilio, L. Hellstrom-Westas, D. Ley, Circulating interferon-gamma and white matter brain damage in preterm infants, Pediatr. Res. 58 (5) (2005) 946–952.
[23] Z.W. Cai, S.Y. Lin, Y. Pang, P.G. Rhodes, Brain injury induced by intracerebral in- jection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat, Pediatr. Res. 56 (3) (2004) 377–384.
[24] A. Patra, H. Huang, J.A. Bauer, P.J. Giannone, Neurological consequences of sys- temic inflammation in the premature neonate, Neural Regen. Res. 12 (6) (2017) 890–896.
[25] J.P. Mizgerd, M.M. Lupa, J. Hjoberg, J.C. Vallone, H.B. Warren, J.P. Butler, et al., Roles for early response cytokines during Escherichia coli pneumonia revealed by mice with combined deficiencies of all signaling receptors for TNF and IL-1, Am. J. Phys. Lung Cell. Mol. Phys. 286 (6) (2004) L1302-L10.
[26] M. Jonsson, J. Agren, S. Norden-Lindeberg, A. Ohlin, U. Hanson, Neonatal en- cephalopathy and the association to asphyxia in labor, Am. J. Obstet. Gynecol. 211(6) (2014).
[27] O. Beharier, J. Kahn, E. Shusterman, E. Sheiner, S100B-a potential biomarker for early detection of neonatal brain damage following asphyxia, J. Matern. Fetal Neonatal Med. 25 (9) (2012) 1523–1528.
[28] F. Liu, S.Y. Yang, Z.F. Du, Z.M. Guo, Dynamic changes of cerebral-specific proteins in full-term newborns with hypoxic-ischemic encephalopathy, Cell Biochem. Biophys. 66 (2) (2013) 389–396.
[29] J. Qian, D. Zhou, Y.W. Wang, Umbilical artery blood S100 beta protein: a tool for the early identification of neonatal hypoxic-ischemic encephalopathy, Eur. J. Pediatr. 168 (1) (2009) 71–77.
[30] J.W. Wirds, A.E.J. Duyn, S.D. Geraerts, E. Preijer, J. van Diemen-Steenvoorde, J.H.S. van Leeuwen, et al., S100 protein content of umbilical cord blood in healthy newborns in relation to mode of delivery, Arch. Dis. Child. 88 (1) (2003) 67–69.
[31] M. Summanen, L. Seikku, P. Rahkonen, V. Stefanovic, K. Teramo, S. Andersson, et al., Comparison of umbilical serum copeptin relative to erythropoietin and S100B as asphyxia biomarkers at birth, Neonatology 112 (1) (2017) 60–66.
[32] L. Impey, C. Greenwood, K. MacQuillan, M. Reynolds, O. Sheil, Fever in labour and neonatal encephalopathy: a prospective cohort study, Br. J. Obstet. Gynaecol. 108 (6) (2001) 594–597.
[33] E. Lieberman, E. Eichenwald, G. Mathur, D. Richardson, L. Heffner, A. Cohen, Intrapartum fever and unexplained seizures in term infants, Pediatrics 106 (5) (2000) 983–988.
[34] M.D. Neufeld, C. Frigon, A.S. Graham, B.A. Mueller, Maternal infection and risk of cerebral palsy in term and preterm infants, J Perinatol: official journal of the California Perinatal Association 25 (2) (2005) 108–113.
[35] T.A.J. Nijman, M.M. Goedhart, C.N. Naaktgeboren, T.R. de Haan, D.C. Vijlbrief, B.W. Mol, et al., Effect of nifedipine and atosiban on perinatal brain injury: sec- ondary analysis of the APOSTEL-III trial, Ultrasound Obstet. Gynecol. 51 (6) (2018) 806–812.